期刊文献+

新疆哈萨克族原发性高血压与心钠素基因T2238C多态性的关系 被引量:8

The relationship between ANP gene T2238C polymorphism and essential hypertension in Xinjiang Kazakans
原文传递
导出
摘要 目的:探讨新疆哈萨克族心钠素基因第3外显子上ScaI酶切位点T2238C多态性与原发性高血压的关系。方法:选择收缩压≥140 mmHg(1 mmHg=0.133 kPa)和(或)舒张压≥90 mmHg的新疆哈萨克族原发性高血压患者313例(高血压组)和年龄、族别相匹配的血压正常者205例(正常对照组),采用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)方法,分别进行心钠素基因T2238C多态性检测,分析高血压组和正常对照组中基因型及等位基因的频率分布及其与高血压的相关性。结果:新疆哈萨克族人心钠素基因T2238C位点存在TT、TC和CC 3种基因型和T、C 2种等位基因。3种基因型在高血压组和正常对照组中的频率分别为87.2%、11.2%、1.6%和91.2%、7.8%、1.0%。T和C等位基因的频率分别为92.8%,7.2%和95.1%,4.9%。基因型及等位基因的频率在2组间均差异无统计学意义(X2=2.013,P>0.05和X2=2.249,P>0.05)。控制了年龄、性别、体质指数等混杂因素后,C等位基因仍与高血压无相关性(β=-0.371,P>0.05),C/T比数比(OR)为0.69,95%CI为0.38-1.25。结论:新疆哈萨克族人心钠素基因T2238C存在基因变异,但该变异可能与哈萨克族人原发性高血压不相关。 Objective: To investigate the relationship between ANP gene T2238C polymorphism and essential hypertension in Xinjiang Kazakans. Method:We selected 313 essential hypertensive patients whose SBP≥140 mmHg and/or DBP≥90 mmHg and 205 normotensive subjects whose BP〈140/90 mmHg of Kazakans in Xinjiang. We measured their ANP gene T2238C polymorphism by PCR-RFLP and tested the association of this polymorphism with hypertension. Result: We had got three kinds of genotypes of T2238C, The distributed frequencies of TT.TC.CC Were 87.2% ,11.2% ,1.6% of hypertensive patients and 91.2% ,7.8% ,1.0% of controls respectively. The distributed frequencies of T and C allele were 92.8%,7.2% of hypertensive patients and 95. 1% ,4.9% of controls respectively. Both of genotypes and allele frequencies had no significant difference between the two groups (X^2=2.013 and X^2 2. 249, P〉0.05). There was no association with 2238Cand hypertension(β=-0.371, P〉0.05). Conclusion:There were three kinds of genotypes of ANP T2238C in Kazakans of Xinjiang. The study suggested the ANP T2238C polymorphism might not be associated with essential hypertension in Kazakans.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2005年第9期513-515,共3页 Journal of Clinical Cardiology
基金 国家自然科学基金(No:30260038 30240045)
关键词 高血压 心钠素 基因多态性 哈萨克族 Hypertension Atrial natriuretie peptide Gene polymorphism Kazakans
  • 相关文献

参考文献8

  • 1李南方,周玲,曹梅,张德莲,祖合热,王新玲,祖菲亚,王君,欧阳玮进,布克力,庞敏,汪迎春,阿不来提,努尔古丽.新疆和丰县牧区高血压病流行病学调查报告[J].现代预防医学,2003,30(2):141-143. 被引量:65
  • 2Levin E R, Gardner D G, Samson W K. Natriuretic peptide. N Engl J Med,1998,339:321-328.
  • 3Ramasawmy R, Kotea N, Lu C Y, et al. Investigation of the polymorphic ScaⅠsite by a PCR-based assay at the human atrial peptides(hANP) gene locus. Hum Gen,1992,90:323-324.
  • 4Nannipieri M, Posadas R, Williams K, et al. Asssociation between polymorphisms of the Atrial Natriuretic Peptide gene and proteinuria:a population-based study.Diabetologia,2003,46:429-432.
  • 5Rutledge D R, Sun Y, Ross E A,et al. Polymorphisms within the atrial natriuretic peptide gene in essential hypertention. J Hypertens , 1995 ,13 :953-955.
  • 6Ciechanowicz A , Kurzawski G, Widecka K, et al . Mutation T →C of nucleotide 2238 in the gene of atrial natriuretic peptide (ANP) precursor and heterogenicity of sodium -sensitive hypertension. Preliminary report .Pol Arch Med Wewn , 1997 ,98 :501-509.
  • 7Kato N, Sugiyama T, Morita H,et al.Genetic analysis of the atrial natriuretic peptide gene in essential hypertention. Clin Sci, 2000,98:251-258.
  • 8Rousse L,Tregouet D A, Hadjadj S,et al.Investigation of the human ANP gene in type 1 diabetic nephropathy. Case-control and follow-up studies.Diabetes,2004,53:1394-1398.

二级参考文献9

  • 1程祖亨 汪师贞.新疆维吾尔自治区不同民族高血压流行病学因素的调查研究[J].新疆医学院学报,1982,5:103-114.
  • 2Yamori Y, Nara Y, Nutritional factors for hypertension and major cardiovascular disease: International cooperative studies for dietary prevention [J] . DMWJpn. 1994, 16: 1825~1841.
  • 3Wu Yingkai, Lu Changqing, Gao Runquan, et al. Nation- Wide Hypertension Screeningin China during 1979~ 1980[J ]. Chinese Medical Journal, 1982, 95: 101~108.
  • 4WHO MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease) : A major international Collaboration[J]. J ClinEpideiol, 1988, 41: 105-114.
  • 5Guidelines Subcommittee of the World Health Organization-International Society of Hypertension Mild Hypertension Liaison Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension[J]. Journal of Hypertension 1999, 17: 151-183.
  • 6Hypertension Prevalence and Status of Awareness, Treatment and Control in China, Tao Shouqi , Wu Xigui , Duan Xiufang et al [J] . Chinese Medical Journal, 1995, 108 (7) : 483~489.
  • 7Stephen W,Macmahon,Graham J et. al Plasma Lipoprotein Levels in treated and Untreated hypertensive Men and Women. The National Heart Foundation of Australia Risk Factor Prevalence Study[J]. Arteriosclerosis, 1985, 5(4): 391-396.
  • 8张兴正 朱明恕 蔡运昌 等.不同民族高血压流行病学因素的调查研究,贵州省威宁县回、汉彝三民族高血压病因学初探[J].中华流行病学杂志,1985,6:281-281.
  • 9吴兆苏,姚崇华,赵冬,吴桂贤,王薇,刘静,曾哲淳,吴英恺,张鸿修,周景春,郭宝霞,冯颖,马隆恩,何厚琦,胡英华,潘信伟,杜福昌,徐修成,胡锡衷,吴宗荣,尹协瑛,陈阳春,张孝慈,杨尔成.我国多省市心血管病趋势及决定因素的人群监测(中国MONICA方案)I.人群危险因素监测结果[J].中华心血管病杂志,1997,25(4):255-259. 被引量:172

共引文献64

同被引文献141

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部